Fibromyalgia of Less Than One Year Duration. Study of Pregabalin
Status:
Withdrawn
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate whether pregabalin is effective in treating subjects
who have had fibromyalgia for less than one year. Pregabalin has been approved by the FDA for
treatment of fibromyalgia. the purpose of the study is to see if subjects identified through
their primary care physicians who have fibromyalgia and have had symptoms for less than one
year respond to pregabalin and to identify characteristics of that response.